Description: Avivagen Inc., a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers products based on its OxC-Beta technology, such as OxC-beta Livestock, a premix for livestock feeds; and Vivamune Health Chews supplements for companion animals. It has operations in Mexico and Latin America. The company was formerly known as Chemaphor, Inc. and changed its name to Avivagen Inc.in May 2012. Avivagen Inc. was founded in 2005 and is headquartered in Ottawa, Canada.
Home Page: www.avivagen.com
100 Sussex Drive
Ottawa,
ON
K1A 0R6
Canada
Phone:
613-702-2908
Officers
| Name | Title |
|---|---|
| Mr. G. F. Kym Anthony | CEO & Vice Chairman |
| Dr. Graham Burton Ph.D. | Co-Founder, Chief Scientific Officer & Director |
| Mr. Ira Levy | Interim Chief Financial Officer |
| Dr. James Nickerson Ph.D. | President and Executive VP of Business Development & Product Innovation |
| Mr. Drew Basek | Director of Investor Relations |
| Ms. Tracy Gillett BVSC | Director of Companion Animal & Marketing Manager |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0.0109 |
| IPO Date: | |
| Fiscal Year End: | October |
| Full Time Employees: | 0 |